Amgen 3Q profit drops 63 percent on charges
Analysts typically exclude one-time items from their estimates.The maker of arthritis drug Enbrel thought revenue increased 3 percent to $3.94 billion, from $3.82 billion a time earlier.Amgen shares were up 27 cents on $59.32 hip after-hours trading.